An intraday high potential, Back Tested Long Analysis.
We ll try to find an entry price within the expected pull back zone 29.50 - 29.98 as previously being back tested.
DETAILS ON THE CHART
NOTE: Entry range area above the entry point, is calculated upon 80% of the recorded pullback back tested past performances
DISCLAIMER: This is a technical analysis study,...
The Medicines Company broke out in a big way last month on heavy volume, sending prices up 40% from the lows. It has held on well over the last few weeks and pulled back 15% on a back test of support.
On the left is the weekly chart. The stochastic 9,3 is a textbook divergence that is playing out and still has some upside. For a longer term swing trade you can...
The Medicines Company (MDCO) has possible stochastic divergence on trend line support at the breakout point of a falling wedge. It put in a nice reversal candle right at trend line crossing and looks ready to turn. Get in on the way up.
Target: 27.84 - 29.34 (3.49% - 9.07%)
MDCO just breaking down some long term support. We think it has good downside potential if it breaks below $37.33
* Trade Criteria *
Date First Found- June 15, 2017
Pattern/Why- Long term support breakdown short
Entry Target Criteria- Break of $37.33
Exit Target Criteria- 1st target $34.33
Stop Loss Criteria- $39.33
Please check back for Trade updates....
MDCO Implied Volatility Rising Ahead Of November Trial Results marketchameleon.com
The Medicines Company is scheduled to release updated drug trial results for its developmental cardiovascular drug MDCO-216 in November. Anticipation for the data is beginning to rise, and the stock has already proven susceptible to notable swings in price as a result...
Upward channel break down in longer frame & formed a pennant now. Money-flow is moving down. We think it will decline around 30
You can check our detailed analysis on MDCO in the trading room/ Executive summery link here-
Time Span: 33:00”
Trade Suggestion Date: 5th Jul
Trade status: waiting for entry confirmation